CDC concurs with panel led by Regenstrief scientist on misapplication of opioid guidelines

CDC concurs with panel led by Regenstrief scientist on misapplication of opioid guidelines

Publication date: May 14, 2019

INDIANAPOLIS — The Centers for Disease Control and Prevention is clarifying its guidelines on opioid prescribing, citing the findings of a review panel led by Regenstrief Institute Research Scientist Kurt Kroenke, M. D. Dr. Kroenke and his colleagues found that many clinicians, policymakers and payers are misapplying the CDC’s guidelines, and those actions are negatively affecting patients.

Dr. Kroenke served as the chair of the American Academy of Pain Medicine Foundation consensus panel created to review the influence of these guidelines on pain management practices.

In addition, the recommendations have been applied to patients outside the guideline’s scope, for example, people in active cancer treatment and those dealing with post-surgical pain.

“The intent of the CDC guidelines was to individualize treatment, but the overly restrictive prescribing policies created by legislatures and payers have led to unintended harm for some patients.

The panel report, “Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report” was published in the April 2019 volume of the journal Pain Medicine.

Concepts Keywords
CDC Pain
Chronic Pain Health
England Articles
Indiana Palliative care
INDIANAPOLIS Medical terminology
Opioid Morphine
Opioids Opioid
Pain Pain management
Pain Management Medical guideline
Protocol Pain management
Stigma Pain
The Panel Chronic pain benefit

Semantics

Type Source Name
gene UNIPROT SMIM10L2B
gene UNIPROT SMIM10L2A
gene UNIPROT FASTK
disease MESH cancer
disease DOID cancer
gene UNIPROT SLC35G1
disease MESH suffering
disease MESH chronic pain
gene UNIPROT BEST1
gene UNIPROT PTPN5
gene UNIPROT ANP32B
gene UNIPROT TNFSF13

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *